Prevention of malignant seeding at drain sites after invasive procedures (surgery and/or thoracoscopy) by hypofractionated radiotherapy in patients with pleural mesothelioma

References

• Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients. J Thorac Cardiovasc Surg 1999; 117: 54–63
   PubMed Web of Science ®Google Scholar
• Zucali PA, Giaccone G. Biology and management of malignant pleural mesothelioma. Eur J Cancer 2006; 42: 2706–14
   PubMedGoogle Scholar
• Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: Comparison of CT and MR imaging. Am J Roentgenol 1999; 172: 1039–47
   PubMed Web of Science ®Google Scholar
• Maggi G, Casadio C, Cianci R, Rena O, Ruffini E. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2001; 19: 346–50
   PubMed Web of Science ®Google Scholar
• Sugarbaker DJ, Garcia JP, Richards WG, Harlpole DH, Jr, Healy-Baldini E, DeCamp MM, Jr, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 1996; 224: 288–94
   PubMedGoogle Scholar
• Chapman E, Berenstein EG, Diéguez M, Ortiz Z. Radiotherapy for malignant pleural mesothelioma. Cochrane Database of Systematic Reviews 2006; Issue 3. Article number CD00388.
   Google Scholar
• Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995; 108: 754–8
   PubMed Web of Science ®Google Scholar
• Ung YC, Yu E, Falkson C, Haynes AE, Stys-Norman D, Evans WK, et al. The role of radiation therapy in malignant pleural mesothelioma: A systematic review. Radiother Oncol 2006; 80: 13–8
   PubMedGoogle Scholar
• Treasure T, Sedrakyan A. Pleural mesothelioma: Little evidence, still time to do trials. Lancet 2004; 364(9440)1183–5
   Google Scholar
• Waite K, Gilligan D. The role of radiotherapy in the treatment of malignant pleural mesothelioma. Clin Oncol 2007; 19: 182–7
   Web of Science ®Google Scholar
• Bydder S, Phillips M, Joseph DJ, Cameron F, Spry NA, DeMelker Y, et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer 2004; 91: 9–10
   PubMed Web of Science ®Google Scholar
• O'Rourke N, Curto Garcia J, Paul J, Hill J, Lawless C, McMenemin R, et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol 2007; 84: 18–22
   PubMed Web of Science ®Google Scholar
• Low EM, Khoury GG, Matthews AW, Neville E. Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy. Clin Oncol 1995; 7: 317–8
   Google Scholar
• West SD, Foord T, Davies RJ. Needle-track metastases and prophylactic radiotherapy for mesothelioma. Respir Med 2006; 100: 1037–40
   PubMed Web of Science ®Google Scholar
• Cellerin L, Garry P, Mahe MA, Chailleux E. Malignant pleural mesothelioma: Radiotherapy for the prevention of seeding nodules. Rev Mal Respir 2004; 21: 53–8
   PubMedGoogle Scholar
• Allen AM, Den R, Wong JS, Zurakowski D, Soto R, Janne PA, et al. Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumectomy. Int J Radiat Oncol Biol Phys 2007; 68: 1366–74
   PubMed Web of Science ®Google Scholar
• Ceresoli GL, Locati LD, Ferreri AJ, Cozzarini C, Passoni P, Melloni G, et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 2001; 34: 279–87
   PubMed Web of Science ®Google Scholar
• Hakkinen AM, Laasonen A, Linmainmaa K, Mattson K, Pyrhonen S. Radiosensitivity of mesothelioma cell lines. Acta Oncol 1996; 35: 451–6
   PubMedGoogle Scholar
• Pinto C, Marini A, De Pangher Manzini V, Benedetti G, Galetta D, Mazzanti P. Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/metotrexate/mytomicin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP I). Lung Cancer 2006; 52: 199–206
   PubMedGoogle Scholar
• De Ruysscher D, Slotman B. Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: A Dutch-Belgian survey. Radiother Oncol 2003; 68: 299–302
   PubMedGoogle Scholar